MedX Health Corp. (TSX-V:MDX) has announced the appointment of Tarek El Hoss as vice president for market development and sales to oversee global initiatives to drive immediate revenue generation and growth.
El Hoss has over 20 years of demonstrated success in the medical technology industry, including as business director for Medtronic (NYSE:MDT) in the Middle East, Africa, Central Asia and Turkey, where he was responsible for driving sales, establishing distribution channels and new product launches, the Ontario-based company noted.
"Over the past year, we've announced commercial partnerships to make our DermSecure skin screening technology available to serve patients throughout Europe, the Middle East and Canada," MedX president and CEO Naman Demaghlatrous said in a statement.
READ: MedX Health launches dermatological screening services in Newfoundland and Labrador with Central Health
"Tarek's extensive knowledge of the global medical technology marketplace and proven expertise in establishing country-specific go-to-market strategies will be crucial to the next phase of our company's growth and we're delighted to have him join our team," he added.
Commenting on his appointment, El Hoss said: "I am excited to join a dynamic team that is driven by a global mindset. Leveraging and strengthening our existing partnerships while seeking out and building others will improve access to our best-in-class, innovative teledermatology platform for patients around the world. I am looking forward to expanding MedX's international footprint and offering a solution to improving patient outcomes at the same time."
MedX is a leading medical device and software company focused on skin health. Its leading SIAscopy on DermSecure telemedicine platform allows healthcare practitioners to quickly and accurately assess suspicious moles, lesions and other skin conditions via its image-capture technology, SIAscopy, and its secure, cloud-based patient management system, DermSecure, which transmits and stores patient data throughout the assessment process.
SIAscopy is the only technology that captures five images, including four spectrophotometric images 2 millimeter below the skin's surface. Teledermatology is a subspecialty of dermatology that offers safe and effective virtual patient assessment and diagnosis at a distance, eliminating the need for in-person appointments.
Contact the author at jon.hopkins@proactiveinvestors.com